title: Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole.
authors.forename: Marie Antoinette
authors.initials: MA
authors.lastname: Frick
authors.forename: Pere
authors.initials: P
authors.lastname: Soler-Palacín
authors.forename: Andrea
authors.initials: A
authors.lastname: Martín Nalda
authors.forename: María Espiau
authors.initials: ME
authors.lastname: Guarner
authors.forename: Concepció Figueras
authors.initials: CF
authors.lastname: Nadal
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007223:Infant; D008297:Male; D009181:Mycoses / Q000188:drug therapy*; D010787:Photosensitivity Disorders / Q000139:chemically induced*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D014230:Triazoles / Q000008:administration & dosage / Q000009:adverse effects*; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole